Transcat (TRNS) Gains from Sales and Divestitures (2014 - 2025)
Transcat's (TRNS) quarterly Gains from Sales and Divestitures came in at $8503.0 in Q4 2025, down 99.88% quarter-over-quarter from $7.3 million in Q3 2025.
Transcat (TRNS) Gains from Sales and Divestitures (2014 - 2025) Analysis & Trends
Transcat has disclosed Gains from Sales and Divestitures across 2 years of filings, most recently posting $8503.0 for Q4 2025.
- Gains from Sales and Divestitures for Q4 2025 came in at $8503.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $8503.0 (changed N/A YoY), and the FY2014 annual result was $52.0, changed N/A from the prior year.
- Gains from Sales and Divestitures came in at $8503.0 for Q4 2025 at Transcat, down from $7.3 million in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $7.3 million in Q3 2025 to a low of $8503.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Cintas | 70.95 Bn | 70.77 Bn | 1.45 Bn |
| 2 | Copart | 29.43 Bn | 26.09 Bn | 1.08 Bn |
| 3 | Rb Global | 20.04 Bn | 19.85 Bn | 869.50 Mn |
| 4 | UL Solutions | 19.54 Bn | 19.30 Bn | 381.00 Mn |
| 5 | Global Payments | 18.52 Bn | 13.33 Bn | 1.70 Bn |
| 6 | Aramark | 14.28 Bn | 13.87 Bn | 426.35 Mn |
| 7 | Relx | 11.84 Bn | 11.60 Bn | - |
| 8 | Amentum Holdings | 5.58 Bn | 5.67 Bn | 345.00 Mn |
| 9 | Dolby Laboratories | 5.00 Bn | 4.42 Bn | 350.90 Mn |
| 10 | Transcat | 847.82 Mn | 844.35 Mn | 25.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | 8,503.00 |
| Dec 27, 2025 | 8,503.00 |
| Sep 27, 2025 | 7.34 Mn |
| Sep 27, 2025 | 7.34 Mn |
| Jun 28, 2014 | 42,000.00 |
| Jun 28, 2014 | 42,000.00 |
| Mar 29, 2014 | 52.00 |
| Mar 29, 2014 | 52.00 |